Oncusp Therapeutics
New York, US · 5 known investors
OnCusp Therapeutics develops oncology therapeutics for cancer treatment, including antibody-drug conjugates and small molecule compounds in clinical and preclinical stages. The company operates as a clinical-stage biopharmaceutical firm advancing multiple programs toward regulatory approval and patient access.
Founders & leadership
DB
Dr. Bing YuanCo-Founder, Chief Executive Officer
DE
Dr. Eric SlosbergCo-Founder, Chief Development Officer
DA
Dr. Andy FuCo-Founder, Chief Business Officer
Investors · 5
In the news
- Inforcer raises $50M to help prepare smaller businesses for a new world of AI and security riskstechcrunch.com · 2026
- Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · 2026
- Seeds | Jumps to World Model Unicorn in One Year! Manifold AI Raises Hundreds of Millions in New Funding | Gasgooautonews.gasgoo.com · 2026
- Fei-Fei Li's World Labs Raises $1B in Fresh Funding to Advance Development of World Modelstheaiinsider.tech · 2026